Zydus Cadila gets DCGI nod for phase-III clinical trials of COVID-19 vaccine
RNS: Zydus Cadila Pharmaceuticals has received approval from the Drugs Controller General of India -DCGI to begin the phase-III clinical …
Zydus Cadila gets DCGI nod for phase-III clinical trials of COVID-19 vaccine Read More